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deformations. The dose distribution is calculated using the 
time-dependent tetrahedral density map issued from 4D-CT 
scans (Petru Manescu, 2014). Unlike image-based methods, 
the deposited energy is accumulated inside each deforming 
tetrahedron of the meshes. An implementation of this dose 
computation method on a deformable anatomy in the case of 
a passive scattering beam line is demonstrated using the 
Geant4 code (Agostinelli, 2003). Besides, energy values in 
voxel-based structures are calculated for each time step and 
accumulated using the transformations provided by the 
registration. Then, values are accumulated back onto the 
reference image and divided by the mass to obtain the 4D 
dose map. Figure 1 illustrates the process used to accumulate 
dose in respiratory-induced simulations.  
 
 
 
 
 
Results: The tetrahedral mesh dose distribution was 
compared to the conventional voxel-based structure using a 
thoracic 4D-CT data of a patient case. Preliminary results 
show that dose distributions for both representations are in a 
good agreement (figure 2), and dose homogeneity is about 
the same (table1). However, motion-induced dose 
accumulations are more intuitive using a tetrahedral model 
since they do not introduce additional uncertainties with 
image resampling and interpolation methods, and also for the 
fact that they respect mass conservation principle. 
 
Conclusion: We have developed a 4D tetrahedral model for 
Monte Carlo dose calculations alongside its implementation 
on the Geant4 platform. Results of comparison with 
conventional methods based on voxels have shown that dose 
distributions are in good agreement. This novel structure can 
be of a great aid for treatment planning of moving targets. 
An experimental validation based on 4D anthropomorphic 
phantom (e.g.  LuCa phantom developed in paul scherrer 
institute) (Neihart, 2013) would draw a clear conclusion 
regarding the performance of the presented method in 
comparison with the classical methods. Nevertheless, the 
main advantage of this method is that, coupled with a 
patient-specific biomechanical model, it could be used in the 
future to correct motion artefacts in treatment planning. 
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Particle Therapy (PT) exploits accelerated charged ions, 
typically protons or carbon ions, for cancer treatments. In PT 
a better dose release accuracy is achieved with respect to 
the conventional radiotherapy, as a consequence of the 
nature of energy deposition processes of charged ions, that 
lose most of their energy near the end of their range, in the 
Bragg Peak (BP) region, preserving healthy tissues and Organ 
At Risk (OAR) around tumor. The high cancer cells killing 
power of this technique requires a precise control of the ion 
beam delivery, and hence target voxel, to take into account 
a possible patient mis-positioning or biological or anatomical 
changes. The development of an on-line dose conformity 
monitoring device is of paramount importance to assure an 
high quality control accuracy in PT treatments. 
In this contribution we propose a novel detector named 
“Dose Profiler” (DP) tailored for dose range monitoring 
applications in PT. The beam range inside the patient will be 
monitored detecting secondary fragments, whose emission is 
correlated to dose release, at large angles with respect to 
the beam direction. The DP is being developed in the 
framework of the INSIDE (Innovative Solutions for In-beam 
Dosimetry in Hadrontherapy) project,   and will be tested at 
CNAO (Centro Nazionale Adroterapia Oncologica), Pavia (IT). 
The detector layout foresee a tracker followed by a 
calorimeter (as shown in Figure 1). Six layers of square 
scintillating fibers, whose light is collected by Silicon 
PhotoMultipliers (SiPMs), provides the x,y particles positions 
used for the charged particles backtracking, while a matrix of 
Figure.2: 4D Dose distributions. Left: accumulated dose 
in tetrahedral mesh. Right: accumulated dose in CT data 
for all phases. Table 1: Evaluation of dose distribution on 
tumor volume. Dmin, Dmax, Dmean are respectively the 
minimum, the maximum and the mean dose deposited. 
Hi (Homogeneity index).  
 
Figure 1. Flow chart of 4D dose accumulation in 
respiratory motion-induced simulation 
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sixteen pixellated LYSO crystals, coupled to multi-anode 
PhotoMultiplier, provides the particle energy measurement. 
The front-end electronics is composed of 4096 channels, and 
the read-out is performed by 128 ASICs (BASIC32_ADC) 
specifically designed for SiPMs read-out application [1], while 
trigger system and data acquisition are implemented with a 
system of 21 FPGAs.  
The detector design and optimization of the detector have 
been performed using Monte Carlo (MC) simulations based on 
the results of experimental measurements ([2], [3]). The DP 
hardware features of DP will be reviewed. The expected 
performance, as resulting from the MC, will be discussed in 
the clinical application framework. 
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We present an isocentric, carbon/proton superconducting 
and permanent magnet proton gantries, respectively, with a 
fixed magnetic field but very large momentum acceptance. 
During a treatment it is possible to do longitudinal and 
transverse spot scanning for the whole energy range 
required. The size and cost are dramatically reduced; for 
example compared to the weight of the Heidelberg 630 tons 
the weight is estimated to be about one tons. The proton 
gantry is of a size of the present PSI gantry, but it is made of 
small permanent Halbach magnets. It can transport very 
precisely the proton beam within a 30-250 MeV kinetic 
energy range, under the permanent magnetic field, with 
variation of the scanning magnets only with an infinite S.A.D.  
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As opposed to surgical disciplines, radiation oncology relies 
on non-invasive imaging of the target volume (tumor, lymph 
nodes or metastases). Apart from anatomical imaging for 
target volume delineation (e.g., CT, MRI), functional imaging 
(e.g., PET, functional CT and MRI) is increasingly being 
integrated in modern radiotherapy techniques. Functional 
imaging is used prior to therapy for guidance, dose-escalation 
strategies and treatment selection, but also early during 
irradiation for response monitoring and consequently 
treatment adaptation. Moreover, functional imaging is 
incorporated in the radiotherapy chain for identification of 
patients at increased risk of normal tissue complications 
(e.g., SPECT and CT for prediction of radiation pneumonitis). 
This presentation will present the current status of functional 
imaging for radiation oncology prior to and during treatment, 
both for the target volume and normal tissues. 
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As compared to photon beams, charged particle therapy such 
as both proton beam therapy (PBT) and carbon-ion 
radiotherapy (CIRT) offers improved dose distribution, 
localizing sufficient dose within a target volume while 
minimizing the dose to the surrounding normal tissues. In 
addition, carbon-ions being heavier than protons provide a 
higher radiobiological effectiveness (RBE), which increases 
with depth reaching the maximum at the end of the beam's 
range. This theoretically is an ideal property from the 
standpoint of cancer radiotherapy.  
In Japan, PBT and CIRT were both initiated at NIRS in 1979 
and 1983, respectively. Since then, various types of tumors 
have been prospectively treated. As of December 2015, there 
are a total of 13 charged particle therapy facilities in 
operation including 9 for PBT and 4 for CIRT.  Several other 
facilities are under construction or being planned for either 
PBT or CIRT. In 2003, we established JCPT (Japan Clinical 
Study Group of Particle Therapy) for the purpose of changing 
information and improving therapeutic techniques for 
charged particle therapy, as well as collecting clinical data 
from existing facilities in Japan. According to the survey of 
JCPT, a total of 30,850 patients were treated in Japan from 
1979 to 2014, including 17,858 patients (58%) with PBT and 
12,922 patients (42%) with CIRT. Male/female was 73%/27%. 
The age of the patients ranging <51, 51-60, 61-70, 71-80, >80 
was 12%, 17%, 34%, 29%, and 8%, respectively. As with the 
tumor types, the major tumors for PBT were prostate (30%), 
liver (19%), H&N (13%), lung (12%), GI (6%) and pancreas (4%), 
and those for CIRT were prostate (24%), H&N (14%), B&S 
(11%), lung (11%), liver (10%) and rectum/pancreas (5% 
each).  
Among 4 facilities for CIRT, the largest numbers of patients 
were treated at NIRS, starting CIRT in 1994 using HIMAC 
(Heavy-ion medical accelerator in Chiba). More than 9,000 
patients have been so far treated based on > 70 protocols, by 
which the benefit of CIRT over other modalities has been 
demonstrated in locally, advanced tumors and non-squamous 
cell types of tumors. Based on their unique biophysical 
characteristics, a significant reduction in overall time and 
fraction has been achieved with minor toxicities. This 
included a single-fraction RT for early-stage NSCLC, one or 
two-fraction RT for liver cancer and 12-fraction RT for 
prostate cancer. Even for other tumors, CIRT with 16 or 
 
Figure 6: Tracker and calorimeter detectors 
